133 related articles for article (PubMed ID: 1658814)
1. Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639.
Boast CA; Leventer S; Sabb A; Abelson M; Bender R; Giacomo D; Maurer S; McArthur S; Mehta O; Morris H
Pharmacol Biochem Behav; 1991 Jun; 39(2):287-92. PubMed ID: 1658814
[TBL] [Abstract][Full Text] [Related]
2. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.
Schumacher C; Steinberg R; Kan JP; Michaud JC; Bourguignon JJ; Wermuth CG; Feltz P; Worms P; Biziere K
Eur J Pharmacol; 1989 Jul; 166(2):139-47. PubMed ID: 2792188
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
Tsukamoto S; Nagaoka H; Igarashi S; Wanibuchi F; Hidaka K; Tamura T
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
[TBL] [Abstract][Full Text] [Related]
5. SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.
Kan JP; Steinberg R; Oury-Donat F; Michaud JC; Thurneyssen O; Terranova JP; Gueudet C; Souilhac J; Brodin R; Boigegrain R
Psychopharmacology (Berl); 1993; 112(2-3):219-27. PubMed ID: 7871023
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
Suzuki T; Uesaka H; Hamajima H; Ikami T
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
Wanibuchi F; Konishi T; Harada M; Terai M; Hidaka K; Tamura T; Tsukamoto S; Usuda S
Eur J Pharmacol; 1990 Oct; 187(3):479-86. PubMed ID: 1963596
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to an anticholinergic agent is paralleled by increased binding to muscarinic receptors in rat brain and increased behavioral response to a centrally active cholinomimetic.
Majocha R; Baldessarini RJ
Life Sci; 1984 Nov; 35(22):2247-55. PubMed ID: 6503612
[TBL] [Abstract][Full Text] [Related]
10. Cholinomimetic activities of minaprine.
Worms P; Kan JP; Steinberg R; Terranova JP; Perio A; Biziere K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):411-8. PubMed ID: 2586634
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
Monsma FJ; Abood LG; Hoss W
Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the coupling of muscarinic M1 receptors to polyphosphoinositide turnover in rat cortical synaptosomes.
Wei JW; Hung WC
Chin J Physiol; 1989; 32(2):103-14. PubMed ID: 2561651
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor subtypes and sexual behavior in female rats.
Dohanich GP; McMullan DM; Cada DA; Mangum KA
Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
[TBL] [Abstract][Full Text] [Related]
14. Chronic, oral aluminum administration to rats: cognition and cholinergic parameters.
Connor DJ; Jope RS; Harrell LE
Pharmacol Biochem Behav; 1988 Oct; 31(2):467-74. PubMed ID: 2854266
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
Xu J; Chuang DM
J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of pirenzepine in the central nervous system. III. Differential effects of multiple pirenzepine and scopolamine administrations on muscarinic receptors as measured autoradiographically.
Messer WS; Thomas GJ; Price M; Hoss W
Brain Res; 1987 Mar; 407(1):46-54. PubMed ID: 3580856
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic drugs regulate passive avoidance performance via the amygdala.
Riekkinen P; Riekkinen M; Sirviö J
J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
[TBL] [Abstract][Full Text] [Related]
18. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
Richards MH
Br J Pharmacol; 1990 Apr; 99(4):753-61. PubMed ID: 1694463
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent changes in receptor-stimulated phosphoinositide turnover in the rat hippocampus.
Tandon P; Mundy WR; Ali SF; Nanry K; Rogers BC; Tilson HA
Pharmacol Biochem Behav; 1991 Apr; 38(4):861-7. PubMed ID: 1651520
[TBL] [Abstract][Full Text] [Related]
20. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
